Literature DB >> 33744146

Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients With Cardiac Amyloidosis.

Peter R Huntjens1, Kathleen W Zhang1, Yuko Soyama1, Maria Karmpalioti1, Daniel J Lenihan1, John Gorcsan2.   

Abstract

OBJECTIVES: The prognostic value of echocardiographic atrial and ventricular strain imaging in patients with biopsy-proven cardiac amyloidosis was assessed.
BACKGROUND: Although left ventricular global longitudinal strain (GLS) is known to be predictive of outcome, the additive prognostic value of left (LA), right atrial (RA), and right ventricular (RV) strain is unclear.
METHODS: One hundred thirty-six patients with cardiac amyloidosis and available follow-up data were studied by endomyocardial biopsy, noncardiac biopsy with supportive cardiac imaging, or autopsy confirmation. One hundred nine patients (80%) had light-chain, 23 (17%) had transthyretin, and 4 (3%) had amyloid A type cardiac amyloidosis. GLS, RV free wall strain, peak longitudinal LA strain, and peak longitudinal RA strain were measured from apical views. Clinical and routine echocardiographic data were compared. All-cause mortality was followed (median 5 years).
RESULTS: Strain data were feasible for GLS in 127 (93%), LA strain in 119 (88%), RA strain in 117 (86%), and RV strain in 102 (75%). Strain values from all 4 chambers were significantly associated with survival. Hazard ratio (HR) and 95% confidence interval (CI) for low median strain values were as follows: GLS, HR: 2.3; 95% CI: 1.3 to 3.8 (p < 0.01); LA strain, HR: 7.5; 95% CI: 3.8 to 14.7 (p < 0.001); RA strain, HR: 3.5; 95% CI: 2.0 to 6.2 (p < 0.001); and RV free wall strain, HR: 2.8; 95% CI: 1.5 to 5.1 (p < 0.001). Peak longitudinal LA strain and RV strain remained independently associated with survival in multivariable analysis. Peak LA strain had the strongest association with survival (p < 0.001), and LA strain combined with GLS and RV free wall strain had the highest prognostic value (p < 0.001).
CONCLUSIONS: Strain data from all 4 chambers had important prognostic associations with survival in patients with biopsy-confirmed cardiac amyloidosis. Peak longitudinal LA strain was particularly associated with prognosis. Atrial and ventricular strain have promise for clinical utility.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac amyloidosis; Echocardiography; Myocardial strain imaging; Prognosis

Year:  2021        PMID: 33744146     DOI: 10.1016/j.jcmg.2021.01.016

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  8 in total

Review 1.  Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography.

Authors:  A Hagendorff; A Helfen; R Brandt; E Altiok; O Breithardt; D Haghi; J Knierim; D Lavall; N Merke; C Sinning; S Stöbe; C Tschöpe; F Knebel; S Ewen
Journal:  Clin Res Cardiol       Date:  2022-06-04       Impact factor: 5.460

Review 2.  Cardiac Imaging for the Assessment of Left Atrial Mechanics Across Heart Failure Stages.

Authors:  Francesco Bandera; Anita Mollo; Matteo Frigelli; Giulia Guglielmi; Nicoletta Ventrella; Maria Concetta Pastore; Matteo Cameli; Marco Guazzi
Journal:  Front Cardiovasc Med       Date:  2022-01-13

Review 3.  Beyond Sarcomeric Hypertrophic Cardiomyopathy: How to Diagnose and Manage Phenocopies.

Authors:  Maurizio Pieroni; Michele Ciabatti; Elisa Saletti; Valentina Tavanti; Pasquale Santangeli; Lucia Martinese; Francesco Liistro; Iacopo Olivotto; Leonardo Bolognese
Journal:  Curr Cardiol Rep       Date:  2022-09-02       Impact factor: 3.955

4.  Left atrial remodeling and the prognostic value of feature tracking derived left atrial strain in patients with light-chain amyloidosis: a cardiovascular magnetic resonance study.

Authors:  Zekun Tan; Yuelong Yang; Wenjian Wang; Hui Liu; Xinyi Wu; Sheng Li; Liwen Li; Liye Zhong; Qiongwen Lin; Hongwen Fei; Pengjun Liao
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-03       Impact factor: 2.357

Review 5.  Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis.

Authors:  Paul J Scheel; Monica Mukherjee; Allison G Hays; Joban Vaishnav
Journal:  Front Cardiovasc Med       Date:  2022-03-24

6.  Development and validation of a predictive model for adverse left ventricular remodeling in NSTEMI patients after primary percutaneous coronary intervention.

Authors:  Lili Wang; Tao Liu; Chaofan Wang; Haochen Xuan; Xianzhi Xu; Jie Yin; Xiaoqun Li; Junhong Chen; Dongye Li; Tongda Xu
Journal:  BMC Cardiovasc Disord       Date:  2022-08-27       Impact factor: 2.174

Review 7.  The Prognostic Importance of Right Ventricular Longitudinal Strain in Patients with Cardiomyopathies, Connective Tissue Diseases, Coronary Artery Disease, and Congenital Heart Diseases.

Authors:  Marijana Tadic; Johannes Kersten; Nicoleta Nita; Leonhard Schneider; Dominik Buckert; Birgid Gonska; Dominik Scharnbeck; Tilman Dahme; Armin Imhof; Evgeny Belyavskiy; Cesare Cuspidi; Wolfgang Rottbauer
Journal:  Diagnostics (Basel)       Date:  2021-05-26

8.  Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathy.

Authors:  Fumi Oike; Hiroki Usuku; Eiichiro Yamamoto; Toshihiro Yamada; Koichi Egashira; Mami Morioka; Masato Nishi; Takashi Komorita; Kyoko Hirakawa; Noriaki Tabata; Kenshi Yamanaga; Koichiro Fujisue; Shinsuke Hanatani; Daisuke Sueta; Yuichiro Arima; Satoshi Araki; Seiji Takashio; Seitaro Oda; Yohei Misumi; Hiroaki Kawano; Kenichi Matsushita; Mitsuharu Ueda; Hirotaka Matsui; Kenichi Tsujita
Journal:  ESC Heart Fail       Date:  2021-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.